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Introduction
The utility and feasibility of ECCO2R in an intensive
care unit (ICU) which doesn’t use ECMO has not been
described. In our general ICU of 15 beds, we don’t use
ECMO and we decided to introduce ECCO2R in COPD
and ARDS patients.
Objectives
The purpose is to describe the feasibility of this techni-
que in our ICU and the actual uses of it.
Materials and Method
We chose ILA ACTIVVE® device (NOVALUNG®) with
MINILUNG® membrane and a double line femoral
catheter (NOVAPORT TWIN 24F). A training for each
member of the team was conducted (physicians and
nurses) and we wrote a detailed procedure between Feb-
ruary 2014 and July 2014. We wrote a procedure for:
the preparation of the device, laying the catheter, moni-
toring, removal of the catheter and the machine, any
malfunctions ...). Between august 2014 and February
2015, data were collected for each patient receiving
ECCO2R. Indication, mortality at J28, duration of
ECCO2R, complications and success of the technique
were evaluated.
Results
During this period, 10 of the 348 patients admitted to
our ICU have received ECCO2R therapy. We included 5
patients with ARDS (we laid the device because tidal
volume (Vt) was 6ml/kg PBW with a PaO2/FiO2 ratio
between 80 and 150, after at least one prone position
session, and with a plateau pressure between 25 and
30cm of water and high level of PaCO2). We included 3
COPD patients in failure of non-invasive ventilation
(NIV) in a hypercapnic coma, 1 asthmatic patient in
severe respiratory acidosis under invasive ventilation
(IV) and 1 severe COPD patient unweaning of the IV.
Patients with ARDS normalized arterial pH, we
decreased Vt (3-4 ml/kg) and respiratory rate. Three of
them are alive at J28 and had received 5, 7 and 14 days
of ECCO2R and 2 of them died under ECCO2R after 16
and 9 days of ECCO2R. The reason of the death was
nosocomial lung infection. None of the COPD patients
with hypercapnic coma were intubated, they received 5,
3, 6 days of ECCO2R and were alive at J28. The asth-
matic patient received 7 days of ECCO2R, was extu-
bated under ECCO2R and was alive at J28. The
unweaning COPD patient was extubated 2 times, reintu-
bated 2 times due to severe neuropathy and tracheal
inhalation. He was tracheotomised and weaned from the
ECCO2R after 19 days, he was alive at J28 but died at J.
There were no bleeding leading by catheter but one
hemothorax requiring a blood transfusion during an
overdosage of heparin.
Conclusions
The ECCO2R in a general ICU could have multiple
indications in COPD and ARDS patients. These indica-
tions remain to be validated but ECCO2R could
improve the management of those patients. The imple-
mentation of ECCO2R is possible but requires a great
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investment, a training of the medical and the paramedi-
cal team and a written detailed procedure.
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